Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma

NCT00255723 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: carboplatin
DRUG: etoposide
DRUG: ifosfamide

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]